AUROBINDO PHARMA
|
AUROBINDO PHARMA Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹5,112 Cr | ₹5,066 Cr | ₹4,380 Cr | ₹2,613 Cr | ₹3,373 Cr |
| Adjustment | ₹2,083 Cr | ₹1,834 Cr | ₹1,496 Cr | ₹1,586 Cr | ₹1,344 Cr |
| Changes In working Capital | ₹164 Cr | ₹-1,244 Cr | ₹-1,675 Cr | ₹-1,095 Cr | ₹1,558 Cr |
| Cash Flow after changes in Working Capital | ₹7,358 Cr | ₹5,656 Cr | ₹4,201 Cr | ₹3,104 Cr | ₹6,275 Cr |
| Cash Flow from Operating Activities | ₹5,526 Cr | ₹3,925 Cr | ₹2,435 Cr | ₹2,387 Cr | ₹5,016 Cr |
| Cash Flow from Investing Activities | ₹-3,459 Cr | ₹-1,876 Cr | ₹-4,256 Cr | ₹-3,978 Cr | ₹-3,212 Cr |
| Cash Flow from Financing Activities | ₹-1,269 Cr | ₹120 Cr | ₹800 Cr | ₹1,814 Cr | ₹-2,969 Cr |
| Net Cash Inflow / Outflow | ₹799 Cr | ₹2,169 Cr | ₹-1,021 Cr | ₹223 Cr | ₹-1,164 Cr |
| Opening Cash & Cash Equivalents | ₹5,564 Cr | ₹3,385 Cr | ₹4,392 Cr | ₹4,163 Cr | ₹5,330 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | ₹0.18 Cr | ₹0.66 Cr | - | ₹6.41 Cr | ₹-3.25 Cr |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | ₹829 Cr | ₹9.10 Cr | ₹14 Cr | ₹-0.06 Cr | ₹0.20 Cr |
| Closing Cash & Cash Equivalent | ₹7,191 Cr | ₹5,564 Cr | ₹3,385 Cr | ₹4,392 Cr | ₹4,163 Cr |
Compare Cashflow Statement of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹90,297.5 Cr | -5.5% | -7.5% | 47.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -5.5% |
-7.5% |
47.1% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses